Welcome to Best Pharmacy at Havmeds! Go shopping!

Product ID: 135316

Reminder: The pictures displayed on this site maybe different from the actual appearance of the product,their maybe a delay in updating the recent picture if their a newly launched packaging from the manufacturer.


ALK-positive non-small cell lung cancer and Non-small cell lung cancer with ROS1 positivity (NSCLC) are treated with pholorla medicine.

Trade name
Pharma 2 Vientiane
Main ingreadient
100mg*30 Capsules
Please negotiate the logistics method with customer service, customer service Whatsapp/Wechat
Please follow the doctor’s advice when taking medicines. The mall only guarantees the quality of the medicines and does not provide medical advice.

Authenticity guarantee

India Direct Mail

Privacy packaging

Pharmacy Direct


Pholorla is an orally accessible, ATP-competitive inhibitor of the receptor tyrosine kinases anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1) with anticancer potential. Lorlatinib binds to and inhibits both ALK and ROS1 kinases after treatment. Inhibition of the kinase causes ALK and ROS1-mediated signaling to be disrupted, which limits tumor cell proliferation in ALK- and ROS1-overexpressing tumor cells. Lorlatinib also can pass the blood-brain barrier.
As Prescribed by Doctor.
Related Products
Copyright 2023 havmeds.com. All Rights Reserved
Call Us